Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry describes a putative long non-coding RNA gene that is transcribed antisense to the ADAMTS9 protein-coding gene. Such antisense RNAs are often detected in large-scale sequencing but are rarely functionally characterized. There is no evidence this RNA is translated, or that its product (if any) has a known biological function. It has no established role as a therapeutic target, disease gene, or biomarker in current literature or major biomedical databases. The provided Ensembl identifier does not resolve to a recognized gene entry in current versions of Ensembl, implying it may be obsolete, incorrect, or uncurated. If your intent was to reference a well-characterized target, it is likely there is an error in the name or ID provided. For the related protein-coding gene, see ADAMTS9, which is a well-known metalloprotease with defined biological and clinical relevance.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to ADAMTS9 (There is no widely recognized abbreviation. ENSG00000300369 is the Ensembl gene ID for this locus, but this ID is not listed in Ensembl’s public resources as an annotated gene, suggesting it could be an internal or obsolete/removed identifier.).